Ahilan has over 20 years of solid experience in the pharmaceutical industry with SmithKline Beecham, American Cyanamid, Wyeth and Goldshield. With an established history of supporting growth initiatives at strategic and operational levels in both small and large pharma, Ahilan is able to bring the breadth and depth of his experience to support specific corporate objectives. His roles have involved advising on product acquisitions , portfolio analysis, new dossier development and registration, executing Europe wide registrations via the centralised, decentralised and mutual recognition procedures, and maintenance of licences in Europe. Ahilan has also served on European Scientific Working Groups in Regulatory, Technical and Pharmacovigilance matters reviewing and advising on proposed EU Legislation. Ahilan's key skills are in the areas of pharmaceutical Regulatory Affairs, product development (NCE, generic and biotech) and strategic due diligence for Mergers and Acquisitions.